Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun-Cheng Wang

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Cancer Communications (London, England)|October 12, 2019
A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomyYang-Xun Pan, Jian-Cong Chen, Ai-Ping Fang, et al.
Surgery|March 29, 2020
Intention to control low central venous pressure reduced blood loss during laparoscopic hepatectomy: A double-blind randomized clinical trialYang-Xun Pan, Jun-Cheng Wang, Xiao-Yun Lu, et al.
Immunity|December 23, 2022
Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinomaRui-Qi Wu, Xiang-Ming Lao, Dong-Ping Chen, et al.
Liver Cancer|January 19, 2026
Pathological Complete Response after Systemic Therapy and Curative Resection in Initially Unresectable Hepatocellular Carcinoma: Feasibility of a Tumor-Free with Drug-Free StrategyQingyang Lin, Wei Peng, Xi Yu, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2021
Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resectionJun-Cheng Wang, Jing-Yu Hou, Jian-Cong Chen, et al.
Journal of Hepatocellular Carcinoma|July 8, 2021
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 PatientsYang-Xun Pan, Xu-Qi Sun, Zi-Li Hu, et al.
Cancer Research|July 8, 2022
PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular CarcinomaJun-Cheng Wang, Dong-Ping Chen, Shi-Xun Lu, et al.
The Journal of Clinical Investigation|April 2, 2026
Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinomaJiong-Liang Wang, Jun-Cheng Wang, Yangxun Pan, et al.
Neoplasia (New York, N.Y.)|March 24, 2026
BPGM as an intrinsic brake to constrain metastasis through phospho-epigenetic-mediated carnitine biosynthesis suppressionMeng-Zhi Wu, Dou Feng, Wu-Ping Liu, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Cancer Communications (London, England)|October 12, 2019
A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomyYang-Xun Pan, Jian-Cong Chen, Ai-Ping Fang, et al.
Surgery|March 29, 2020
Intention to control low central venous pressure reduced blood loss during laparoscopic hepatectomy: A double-blind randomized clinical trialYang-Xun Pan, Jun-Cheng Wang, Xiao-Yun Lu, et al.
Immunity|December 23, 2022
Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinomaRui-Qi Wu, Xiang-Ming Lao, Dong-Ping Chen, et al.
Liver Cancer|January 19, 2026
Pathological Complete Response after Systemic Therapy and Curative Resection in Initially Unresectable Hepatocellular Carcinoma: Feasibility of a Tumor-Free with Drug-Free StrategyQingyang Lin, Wei Peng, Xi Yu, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2021
Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resectionJun-Cheng Wang, Jing-Yu Hou, Jian-Cong Chen, et al.
Journal of Hepatocellular Carcinoma|July 8, 2021
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 PatientsYang-Xun Pan, Xu-Qi Sun, Zi-Li Hu, et al.
Cancer Research|July 8, 2022
PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular CarcinomaJun-Cheng Wang, Dong-Ping Chen, Shi-Xun Lu, et al.
The Journal of Clinical Investigation|April 2, 2026
Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinomaJiong-Liang Wang, Jun-Cheng Wang, Yangxun Pan, et al.
Neoplasia (New York, N.Y.)|March 24, 2026
BPGM as an intrinsic brake to constrain metastasis through phospho-epigenetic-mediated carnitine biosynthesis suppressionMeng-Zhi Wu, Dou Feng, Wu-Ping Liu, et al.
Pageof 4